Semagglutide (known commercially as Ozempic) has been one of the most revolutionary drugs in recent years for the treatment of diabetes and obesity, and is rapidly expanding around the world, but in Chile the arrival of generic drugs could be facing a complex—and slow—stage.
Semagglutide (known commercially as Ozempic) has been one of the most revolutionary drugs in recent years for the treatment of diabetes and obesity, and is rapidly expanding around the world, but in Chile the arrival of generic drugs could be facing a complex—and slow—stage.